Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562

A multi-center study from the French Myelodysplastic Syndrome (MDS) Group confirmed that iron chelation therapy is an independent prognostic factor that can increase the survival rate of patients who are suffering from transfusion-dependent low-risk MDS. In this study, we aimed to explore this clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nianyi, Chen, Qinfen, Gu, Jingwen, Li, Shuang, Zhao, Guangjie, Wang, Wei, Wang, Zhicheng, Wang, Xiaoqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482673/
https://www.ncbi.nlm.nih.gov/pubmed/28388554
http://dx.doi.org/10.18632/oncotarget.16583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482673/
https://www.ncbi.nlm.nih.gov/pubmed/28388554
http://dx.doi.org/10.18632/oncotarget.16583

Ejemplares similares